Mia's Feed
Medical News & Research

As Mosquito Season Peaks, Health Officials Prepare for a New Normal of Dengue Cases

As Mosquito Season Peaks, Health Officials Prepare for a New Normal of Dengue Cases

Share this article

Public health officials prepare for an increase in dengue fever cases amid rising mosquito populations, climate change, and limited vaccine options, signaling a potential new normal in the U.S.

3 min read

As the summer months arrive, bringing peak mosquito activity, public health officials are preparing for a possible surge in dengue fever cases across regions where the disease is becoming more prevalent. Climate change, urbanization, and the absence of a widely available vaccine contribute to concerns that dengue may become endemic in larger parts of North America. According to recent data from the CDC, approximately 3,700 cases of dengue were reported in the United States last year, a significant increase from the previous year, with more cases being acquired locally, particularly in California, Florida, and Texas.

Dengue is traditionally endemic in tropical and subtropical regions, including Latin America, Southeast Asia, and India, with cases rising sharply in many areas last year. Historically, the United States had few local dengue cases; most infections were contracted abroad. However, recent decades have seen increased local transmission, especially in Puerto Rico, which experienced a public health emergency in 2024 due to a spike in cases.

In California, the spread of dengue is linked to the presence of Aedes aegypti and Aedes albopictus mosquitoes — vectors for the disease — which were not known to exist in the state 25 years ago. Now, these mosquitoes are found in over 400 communities across 25 counties, predominantly in Southern California and the Central Valley. The expansion of these vectors heightens the risk of disease transmission, especially as climate change fosters warmer urban environments favorable to mosquito breeding.

Most dengue infections are asymptomatic; however, symptomatic cases can include high fever, severe headaches, muscle and joint pain, bleeding, and in extreme cases, death. Diagnosing dengue can be challenging due to the lack of rapid, widely available tests. Healthcare providers are advised to consider recent travel history when diagnosing febrile illnesses.

Preventive measures include removing standing water where mosquitoes breed, using insect repellents, and avoiding outdoor activities during peak biting times at dawn and dusk. Efforts to control mosquito populations intensified after wildfires scorched parts of Los Angeles, which left many abandoned pools and other breeding sites. Local agencies are deploying various strategies, including treating stagnant water sources and exploring innovative methods like releasing sterilized mosquitoes.

Federal support for dengue and other climate-related health research appears to be waning, as the NIH reportedly plans to cut funding for new climate change studies, potentially impacting future vaccine and intervention development. Currently, vaccine options are limited: one for children is facing discontinuation due to low demand, and others are not available in the U.S.

Experts warn that without effective vaccines and antiviral treatments, dengue could establish itself as an endemic disease in the U.S. Future outbreaks remain uncertain but could become more severe with ongoing environmental changes. Researchers at institutions like the La Jolla Institute are actively working to develop more effective vaccines, aiming to reduce the disease burden.

Overall, the rising presence of dengue in the U.S. underscores the importance of vigilant mosquito control, public education, and continued research efforts to mitigate the expanding threat of this mosquito-borne disease.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

New Biomarker Panel Enhances Prediction of CKD Progression in Children

A groundbreaking biomarker panel developed by Yale researchers improves the prediction of chronic kidney disease progression in children, supporting personalized care and better outcomes.

Implications of Reclassifying Marijuana for Medical Research

Reclassifying marijuana from Schedule I to Schedule III could significantly enhance medical research, improve patient access, and promote industry growth by reducing current federal restrictions on cannabis studies.

Lower Doses of GLP-1 Medication Achieve Similar Weight Loss as Higher Doses, Danish Study Shows

A Danish study reveals that lower doses of semaglutide, combined with lifestyle and psychological support, can achieve weight loss similar to higher doses used in clinical trials, offering a promising approach to obesity management.

Erythropoietin as a Promising Therapeutic Agent for Myelin Formation and Cognitive Health

New research reveals erythropoietin's role in promoting myelin formation in the brain, offering promising avenues for treating cognitive disorders and neurodegenerative diseases. Discover how this growth factor influences brain cell maturation and cognitive health.